CHU - Hopital Nord

Saint-Etienne 42055

0 studies enrolling now · 3 studies all time

What they study most

Assess the Benefits From the AAISafeR/SafeR Algorithm of Symphony 2550 or REPLYTM DR in a Wide Range of Pacemaker Patients., Heart Failure NYHA Class III and Ambulatory IV, Non-small Cell Lung Cancer

Studies at this site

• Clinical Trial of the SonRtip Lead and Automatic AV-VV Optimization Algorithm in the PARADYM RF SonR CRT-D — Status unconfirmed
• Evaluation of the SafeR Mode in Patients With a Dual Chamber Pacemaker Indication — Completed
• Evaluation of Efficacy, Safety and Tolerability of Targretin Capsules in Patients With Advanced or Metastatic Non-small Cell Lung Cancer — Completed